Surviving Sepsis Campaign 2026
Surviving Sepsis Campaign 2026
Source: SSC 2026 · Published simultaneously in Critical Care Medicine & Intensive Care Medicine · March 23, 2026
The big picture
The 2026 SSC guidelines update the 2021 version and represent the most comprehensive revision to date. A 69-person international panel from 23 countries — including significant LMIC representation — produced 129 statements using GRADE methodology. The defining theme of this edition is more decisive recommendations: many previously conditional statements have been upgraded, and new topics (post-sepsis care, prehospital management, fluid removal) are formally addressed for the first time.
Definition reminder (Sepsis-3): Sepsis = life-threatening organ dysfunction due to infection. Septic shock = sepsis + circulatory failure conferring higher mortality (vasopressors needed to maintain MAP ≥65 + lactate >2 mmol/L despite adequate fluids).
1 · System-level: institutions must act
The guidelines open with a strong message for hospitals — sepsis improvement is a institutional responsibility, not just a bedside skill.
Strong recommendation: Hospitals must implement a performance improvement programme (PIP) — including sepsis screening for acutely ill patients, standardised treatment protocols, and QI feedback loops. This is one of only four strong recommendations backed by moderate-to-high quality evidence.
Code sepsis / sepsis huddle
Use multidisciplinary "code sepsis" or "sepsis huddle" protocols to expedite diagnosis and treatment. Evidence is low certainty but the concept is endorsed — think of it like a trauma call, but for infection. Implementation will vary by hospital.
2 · Screening and early recognition
Strong recommendation — know this one: In acutely ill hospital patients, use NEWS, NEWS2, MEWS, or SIRS over qSOFA as a single screening tool. qSOFA has poor sensitivity and misses too many septic patients.
qSOFA is not dead — it remains useful for identifying clinical deterioration and as a prognostic tool — but it should never be the only screening method. Sepsis is a clinical diagnosis. No single biomarker rules it in or out.
Novel biomarkers & diagnostics
Pancreatic stone protein (PSP) makes a notable appearance — it now has sufficient evidence to be mentioned in the guidelines as a potentially useful biomarker. However, most novel tests still lack sufficient evidence for routine use. Use them to support risk stratification, not replace clinical judgement.
Prehospital
New for 2026: use structured screening tools in prehospital settings and notify the receiving hospital early. This allows the ED team to prepare — blood cultures, antibiotics, IV access — before the patient arrives.
3 · Antimicrobials — the most important drug you give
The headline: Early antibiotics remain the single most effective mortality-reducing intervention in sepsis. In septic shock or definite/probable sepsis — give antibiotics immediately, ideally within 1 hour of recognition.
Timing by clinical picture
Septic shock or definite/probable sepsis
Antibiotics immediately — target within 1 hour. Do not wait for blood culture results.
Probable sepsis without shock
Antibiotics immediately — also within 1 hour. Brief evaluation acceptable but should not delay therapy.
Possible sepsis, low infection risk, no shock
Up to 3 hours of rapid evaluation is acceptable before committing to antibiotics. Monitor closely and reassess constantly. If uncertain, treat.
Prehospital (new!)
If the patient has definite/probable septic shock AND anticipated time to hospital ≥60 minutes — administer antibiotics during transport.
Blood cultures first — but don't let them delay treatment
Get blood cultures before antibiotics whenever possible. This supports de-escalation and stewardship. But if drawing cultures will meaningfully delay therapy, give the antibiotics first.
Beta-lactam infusion strategy Upgraded
Now a strong recommendation: Use prolonged (extended) infusion of beta-lactams for maintenance dosing — after an initial loading bolus — over conventional bolus infusion. This maximises the time-dependent pharmacodynamics of beta-lactams (maximise % time above MIC). Give the loading dose fast, then run the rest over 3–4 hours.
De-escalation Upgraded
Now a strong recommendation: De-escalate antimicrobial therapy once you have a confirmed microbiological diagnosis and susceptibility profile. Stewardship is not optional — it is now a strong recommendation.
Quick check — antibiotics
A 58-year-old arrives from a nursing home, febrile, confused, BP 88/56. Most likely septic shock. What do you do first?
4 · Fluid resuscitation — smarter, not just more
The 2026 guidelines bring important nuance to fluids. The 30 mL/kg initial resuscitation target remains, but the message is now: assess, reassess, and then stop or remove.
Initial resuscitation
Give at least 30 mL/kg IV crystalloid within the first 3 hours for sepsis-induced hypoperfusion or septic shock. Reassess frequently — the goal is adequate perfusion, not a fixed volume target.
Which fluid? Upgraded
Balanced crystalloids (e.g. Plasmalyte, Hartmann's/LR) over 0.9% saline — upgraded from suggest to stronger recommend
Albumin as a supplement to crystalloids — no benefit shown; crystalloids alone are suggested
Starches (HES) — not recommended, risk of AKI and bleeding
After initial resuscitation — liberal vs restrictive Upgraded
For patients who received 30 mL/kg and still have persistent hypoperfusion, use either a liberal or restrictive strategy based on individual patient and healthcare system factors. This is a significant upgrade from 2021 where no recommendation could be made. The key takeaway: there is no universal answer — use dynamic measures to guide you.
Active fluid removal — new recommendation
Brand new in 2026: After the acute resuscitation phase, actively remove fluid (diuretics; if insufficient, ultrafiltration/CRRT). Fluid overload is harmful. Once the patient is stabilised and vasopressors are weaning, start deresuscitation.
Monitoring resuscitation — what to use
Dynamic measures (pulse pressure variation, stroke volume variation, passive leg raise response) over static measures (CVP, PCWP)
Serial lactate measurements to guide resuscitation in patients with elevated lactate or septic shock
Capillary refill time as an adjunct to other perfusion monitors — simple, bedside, free
Minimally/non-invasive cardiac output monitoring — not enough data to recommend routinely adding to usual care
5 · Vasopressors and haemodynamics
MAP targets
MAP ≥65 mmHg — strong recommendation. Higher targets show no mortality benefit and increase arrhythmia risk.
MAP 60–65 mmHg is acceptable. Lower targets are safe in older patients and reduce vasopressor burden.
Vasopressor choice
Peripheral vasopressors New
New 2026 recommendation: Start vasopressors peripherally to restore MAP rather than waiting for central venous access. Delays caused by waiting for a central line cost lives. Once a central line is placed, transition — but don't wait.
Corticosteroids Downgraded
Steroids (IV hydrocortisone 200 mg/day) may be used in septic shock — downgraded from "ongoing vasopressor requirement" to a more general conditional suggestion. Clinical judgement about disease severity should guide use.
6 · Source control
Treat the source, not just the symptoms. Rapidly identify and control the infectious source — drain abscesses, remove infected devices, debride necrotic tissue. Target within 6–12 hours of diagnosis where possible. No antibiotic will work if the source is not controlled.
Evidence base is mostly observational, but the principle is biologically sound and clinically endorsed. In the ED: scan early, call surgery early, intervene early.
7 · What the guidelines say to avoid
Blood purification therapies (hemoperfusion, high-dose hemofiltration, plasma exchange) — expanded from just polymyxin B in 2021
Probiotics in sepsis/septic shock — very low certainty evidence
qSOFA as sole screening tool — misses too many patients
Targeting MAP >65 mmHg — higher targets increase arrhythmia without improving outcomes
Liberal transfusion strategy — use restrictive (Hb threshold ~7 g/dL), moderate certainty
8 · Post-sepsis care — a new frontier
The 2026 guidelines formally address what happens after the ICU for the first time. Sepsis survivors suffer significant long-term morbidity — physical deconditioning, cognitive impairment, psychological disorders (PTSD, depression), and new organ dysfunction.
There is currently insufficient evidence to recommend specific cognition-targeted therapies post-hospitalisation. However, the guidelines suggest assessing for post-sepsis morbidity, educating patients and families about what to expect, and following up survivors proactively. The "Post-Intensive Care Syndrome (PICS)" framework is implicitly endorsed.
For your lectures: frame this as the "fifth vital sign" of sepsis care — survival is not the finish line. Ask your ICU survivors about their sleep, memory, mood, and function.
Summary — the 8 things to remember
Recognise early
Use NEWS/MEWS/SIRS — not qSOFA alone. Sepsis is a clinical diagnosis.
Get blood cultures, then antibiotics immediately
Don't let cultures delay treatment. In shock: antibiotics within 1 hour. In possible sepsis without shock: up to 3 hours of evaluation.
Resuscitate with balanced crystalloids
30 mL/kg initial bolus, reassess constantly. Balanced crystalloids over saline.
Start vasopressors peripherally if needed
Don't wait for a central line. Target MAP ≥65 (60–65 if age ≥65). Noradrenaline first.
Prolonged beta-lactam infusion
Loading bolus, then extended infusion — now a strong recommendation.
Control the source
Drain, remove, debride — ideally within 6–12 hours.
De-escalate once you have culture data
Stewardship is a strong recommendation, not just good practice.
Remove excess fluid after resuscitation
Active DE resuscitation once stable — new in 2026
"Recognize early, culture early, treat infection promptly, give fluids thoughtfully, start norepinephrine early when needed, control the source, and reassess continuously.